264 filings
Page 9 of 14
8-K
5qmc6wbjr1pa
30 Jul 20
Other Events
8:21am
8-K
jor4a
27 Jul 20
Other Events
8:35am
8-K
7an 8u1ki
10 Jun 20
Submission of Matters to a Vote of Security Holders
5:03pm
UPLOAD
9ibuq09yy9pwk
27 May 20
Letter from SEC
12:00am
10-K/A
uk9 wtt24myter
21 May 20
Annual report (amended)
4:15pm
CORRESP
ypfzwa0r4n5e5
15 May 20
Correspondence with SEC
12:00am
8-K
v2mh2au
14 May 20
Eton Pharmaceuticals Announces First Quarter 2020 Financial Results
4:09pm
8-K
x23hx5kw x6l083unm
7 May 20
Other Events
4:25pm
8-K
o2z3v8jjsi3h1yzubnq8
6 May 20
Entry into a Material Definitive Agreement
5:02pm
UPLOAD
ds6ucnuh n062dw2eo9
5 May 20
Letter from SEC
12:00am
8-K
2p5z3vssw91q0
4 May 20
Eton Pharmaceuticals Announces Appointment of Paul Stickler as Senior Vice President of Sales and Marketing
8:29am
DEFA14A
cpb4tj
22 Apr 20
Additional proxy soliciting materials
5:04pm
D
iedwhaf0iq2oyiv45 0v
8 Apr 20
$7.5M in equity, sold $7.5M, 2 investors
8:48am
SC 13G/A
83dxpg d1
7 Apr 20
Eton Pharmaceuticals / Opaleye Management ownership change
12:00am
3
tg2d7
6 Apr 20
Initial statement of insider ownership
7:16pm
424B5
mewaicu
30 Mar 20
Prospectus supplement for primary offering
8:39am
8-K
58g yt5hw7azhd0z
30 Mar 20
Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug AlkindiĀ® Sprinkle
8:32am